What is Zacks Research’s Estimate for Docusign Q1 Earnings?

Docusign Inc. (NASDAQ:DOCU) – Equities researchers at Zacks Research boosted their Q1 2027 earnings estimates for shares of Docusign in a note issued to investors on Wednesday, December 24th. Zacks Research analyst Team now expects that the company will post earnings per share of $0.32 for the quarter, up from their previous forecast of $0.30. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Docusign’s current full-year earnings is $1.17 per share.

A number of other research firms also recently weighed in on DOCU. Bank of America dropped their price target on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. BTIG Research assumed coverage on shares of Docusign in a research note on Tuesday, December 16th. They issued a “buy” rating and a $88.00 price objective on the stock. Wedbush lowered their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Argus reaffirmed a “hold” rating on shares of Docusign in a research note on Monday, September 8th. Finally, Wells Fargo & Company lowered their price target on shares of Docusign from $85.00 to $75.00 and set an “equal weight” rating on the stock in a report on Friday, December 5th. Six investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $86.80.

Docusign Trading Down 0.7%

NASDAQ DOCU opened at $69.47 on Monday. Docusign has a 12 month low of $63.41 and a 12 month high of $99.30. The stock has a 50 day moving average of $69.09 and a 200-day moving average of $73.37. The company has a market cap of $13.91 billion, a PE ratio of 48.58, a PEG ratio of 3.51 and a beta of 0.98.

Insider Activity

In other news, insider Robert Chatwani sold 13,818 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total transaction of $944,183.94. Following the transaction, the insider directly owned 70,197 shares in the company, valued at approximately $4,796,561.01. This trade represents a 16.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Blake Jeffrey Grayson sold 9,515 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total value of $650,159.95. Following the completion of the transaction, the chief financial officer directly owned 118,213 shares of the company’s stock, valued at $8,077,494.29. The trade was a 7.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 87,542 shares of company stock worth $6,097,905 in the last three months. Corporate insiders own 1.66% of the company’s stock.

Institutional Investors Weigh In On Docusign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Banque Transatlantique SA acquired a new stake in shares of Docusign during the 1st quarter valued at about $26,000. Rise Advisors LLC grew its holdings in shares of Docusign by 864.6% in the 1st quarter. Rise Advisors LLC now owns 463 shares of the company’s stock valued at $38,000 after acquiring an additional 415 shares in the last quarter. WPG Advisers LLC acquired a new position in shares of Docusign during the 1st quarter worth approximately $39,000. Twin Peaks Wealth Advisors LLC acquired a new position in Docusign during the second quarter valued at approximately $43,000. Finally, SJS Investment Consulting Inc. grew its position in Docusign by 5,318.2% in the third quarter. SJS Investment Consulting Inc. now owns 596 shares of the company’s stock valued at $43,000 after acquiring an additional 585 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.